The American College of Radiology (ACR) said it applauded the inclusion of multiple ACR-backed provisions in the U.S. House of Representatives Labor, Health and Human Services, Education, and Related Agencies’ fiscal year (FY) 2026 spending bill.
The bill reflects guidance by the House Committee on Appropriations that encourages the National Cancer Institute to continue to integrate imaging technologies into clinical trials, calling scans a “known necessity for a cancer diagnosis and treatment,” the ACR noted, in a September 10 statement.
The legislation also supports increased funding for women’s health research, modern breast cancer screening trials, focused ultrasound, theranostics techniques, and efforts to improve diversity in clinical research. In addition, the ACR said it agrees with the committee report that imaging “should continue to hold a core function in the clinical trial process.”
“The House Appropriations Committee is correct that radiology exams are ‘essential components of cancer diagnosis and treatment’ and for other diseases, illnesses, and injuries,” said ACR CEO Dana Smetherman, MD. “We urge Congress to pass final legislation that reflects this approach and retains ACR-backed provisions that can save lives.”
More information about radiology provisions in the FY26 Appropriations Bill is available on the ACR website.
